D.A. Davidson & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

D.A. Davidson & Co’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.55M	Buy	+60,735	New	+$1.93M	0.01%	668
2025 Q4	–	Sell	-50,112	Closed	-$1.39M	–	1532
2025 Q3	$1.39M	Buy	+50,112	New	+$1.27M	0.01%	761
2025 Q2	–	Sell	-34,723	Closed	-$721K	–	1448
2025 Q1	$721K	Buy	+34,723	New	+$872K	0.01%	889
2021 Q4	–	Sell	-3,822	Closed	-$286K	–	1266
2021 Q3	$286K	Buy	3,822 +1,632	+75%	+$137K	﹤0.01%	1032
2021 Q2	$203K	Sell	2,190 -978	-31%	-$83.2K	﹤0.01%	1130
2021 Q1	$281K	Buy	+3,168	New	+$314K	﹤0.01%	975

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

D.A. Davidson & Co's ARKG Position: Q2 2026 in Review

D.A. Davidson & Co opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 60,735 shares worth $2.55M. The stake represents 0.01% of the portfolio and ranks #668 among its holdings. This is a return to the name: D.A. Davidson & Co previously reported a position in ARKG as recently as Q3 2025.

D.A. Davidson & Co first reported a position in ARKG in Q1 2021 and has held it in 6 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

D.A. Davidson & Co held 60,735 shares of ARK Genomic Revolution ETF worth $2.55M as of Q2 2026.
ARK Genomic Revolution ETF was a new D.A. Davidson & Co position in Q2 2026.
ARK Genomic Revolution ETF made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #668 holding.
D.A. Davidson & Co first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 6 quarters since.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.